Hydrochloric Acid → HCID 89077752, 화합물
반응식
[CH3:1][C:2]1([CH3:28])[C:10]2[C:5](=[CH:6][CH:7]=[C:8]([C:11]([O-:13])=O)[CH:9]=2)[N+:4]2[CH:14]=[CH:15][C:16]([C:18]3[C:26]4[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=4)[N:20]([CH3:27])[CH:19]=3)=[CH:17][C:3]1=2.[ClH:29].[C:30]([N:37]1[CH:41]=[CH:40]N=[CH:38]1)(N1C=CN=C1)=O.Cl.Cl.[NH2:44][CH2:45][CH2:46][S:47][S:48][CH2:49][CH2:50][NH2:51]>CN1CCCC1=O.O1CCOCC1.C(OCC)C.C(N(C(C)C)CC)(C)C.CC(C)=O>[Cl-:29].[Cl-:29].[S:47]([CH2:46][CH2:45][NH:44][C:11]([C:8]1[CH:9]=[C:10]2[C:5](=[CH:6][CH:7]=1)[N+:4]1[CH:14]=[CH:15][C:16]([C:18]3[C:26]4[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=4)[N:20]([CH3:27])[CH:19]=3)=[CH:17][C:3]=1[C:2]2([CH3:1])[CH3:28])=[O:13])[S:48][CH2:49][CH2:50][NH:51][C:11]([C:8]1[CH:9]=[C:10]2[C:5](=[CH:6][CH:7]=1)[N+:4]1[CH:14]=[CH:15][C:16]([C:40]3[C:25]4[C:38](=[CH:23][CH:22]=[CH:21][CH:26]=4)[N:37]([CH3:30])[CH:41]=3)=[CH:17][C:3]=1[C:2]2([CH3:28])[CH3:1])=[O:13]참가 물질
10
반응물 4
생성물 1
시약·촉매·용매 5
실험 절차
10,10-dimethyl-8-(1-methyl-1H-indol-3-yl)-10H-pyrido-[1,2-a]indolium-2-carboxylate 0.37 g was solubilized in 5 mL N-methylpyrrolidinone (NMP), a solution of HCl in dry dioxane and diethyl ether (1 mL; 1N; 1:3) was added and 1,1′-carbonyldiimidazole (320 mg) was progressively added. After 3 h, 200 mg of cystamine dihyrochloride in mL diisopropylethylamine (DIPEA) were added to the mixture. After 24 h, the reaction mixture was poured in 100 mL acetone. The resulting solid was filtered, washed with acetone and dried under vacuum (340 mg, yellow powder). Analyses were in accordance with the expected structure.
후처리
- waitAfter 24 h
- filtrationThe resulting solid was filtered
- washwashed with acetone
- customdried under vacuum (340 mg, yellow powder)
출처 및 근거
- ORD 기록
- ord-38778b693abf47bc90b7d54082ae4183
- 출처 데이터셋
- uspto-grants-2013_03
- 특허 번호
- US08398722B2
반응 노트
불러오는 중…